招银国际：美国针对创新药将加征关税预期对CXO影响有限推荐买入三生制药(01530)等

智通财经2025-09-30

智通财经APP获悉，招银国际发布研报称，预期中美创新合作将持续，中国国内创新研发需求回暖。MSCI中国医疗指数2025年初至今累计上涨 74.0%，跑赢MSCI中国指数37.3%。由于资本市场融资复苏、创新药出海交易规模上涨，国内创新药研发需求出现回暖。该行注意到，创新药研发所需的实验猴的中标价格已经从2024年中的约8.5万元回升至约9万元。叠加美国降息，CXO 行业有望在下半年迎来业绩修复。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2571142633?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-30 15:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571142633","market":"fut","top_or_hot":-1,"title":"招银国际：美国针对创新药将加征关税预期对CXO影响有限 推荐买入三生制药(01530)等","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，招银国际发布研报称，预期中美创新合作将持续，中国国内创新研发需求回暖。MSCI中国医疗指数2025年初至今累计上涨 74.0%，跑赢MSCI中国指数37.3%。由于资本市场融资复苏、创新药出海交易规模上涨，国内创新药研发需求出现回暖。该行注意到，创新药研发所需的实验猴的中标价格已经从2024年中的约8.5万元回升至约9万元。叠加美国降息，CXO 行业有望在下半年迎来业绩修复。...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1351203.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>招银国际：美国针对创新药将加征关税预期对CXO影响有限 推荐买入三生制药(01530)等</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n招银国际：美国针对创新药将加征关税预期对CXO影响有限 推荐买入三生制药(01530)等\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-30 15:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1351203.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，招银国际发布研报称，预期中美创新合作将持续，中国国内创新研发需求回暖。MSCI中国医疗指数2025年初至今累计上涨 74.0%，跑赢MSCI中国指数37.3%。由于资本市场融资复苏、创新药出海交易规模上涨，国内创新药研发需求出现回暖。该行注意到，创新药研发所需的实验猴的中标价格已经从2024年中的约8.5万元回升至约9万元。叠加美国降息，CXO 行业有望在下半年迎来业绩修复。...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1351203.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1351203.html","article_id":"2571142633","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571142633","pubTimestamp":1759219015,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，招银国际发布研报称，预期中美创新合作将持续，中国国内创新研发需求回暖。叠加美国降息，CXO 行业有望在下半年迎来业绩修复。而美国针对创新药将加征关税，预期对CXO影响有限。特朗普于9月25日宣布，除非制药商正在美国建设工厂，否则从10月1日开始，专利药品将面临100%的关税。由于多家跨国药企已有美国建厂计划，因此或将不受影响。推荐买入三生制药、巨子生物、药明合联、固生堂、中国生物制药、信达生物 。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","01530":"三生制药","06978":"永泰生物-B","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","02273":"固生堂","BK1589":"北水核心资产","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","BK1207":"个人用品","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","02367":"巨子生物","BK1219":"保健护理服务","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","01177":"中国生物制药","BK1141":"生命科学工具和服务","BK1191":"制药","IE00BZ08YR35.GBP":"GUINNESS BEST OF CHINA \"C\" (GBP) ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","BK1161":"生物科技","BK1593":"医美概念股","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","IE00BZ08YS42.EUR":"GUINNESS BEST OF CHINA \"C\" (EUR) ACC","02268":"药明合联","IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","01801":"信达生物","BK1515":"抗疫概念","SG9999014674.SGD":"Nikko AM All China Equity A SGD","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","BK1574":"生物医药B类股","CXO":"康休","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","BK1583":"高瓴概念","BK1521":"挪威政府全球养老基金持仓","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD"},"translate_title":"CMB International: The United States will impose additional tariffs on innovative drugs, which is expected to have a limited impact on CXO. It is recommended to buy 3SBio (01530) and others","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1.5,"CXO":1.5,"01530":1.5,"02367":0.9,"06978":1.5,"02273":0.9,"01177":0.9,"01801":0.9,"02268":0.9},"content_text":"智通财经APP获悉，招银国际发布研报称，预期中美创新合作将持续，中国国内创新研发需求回暖。MSCI中国医疗指数2025年初至今累计上涨 74.0%，跑赢MSCI中国指数37.3%。由于资本市场融资复苏、创新药出海交易规模上涨，国内创新药研发需求出现回暖。该行注意到，创新药研发所需的实验猴的中标价格已经从2024年中的约8.5万元回升至约9万元。叠加美国降息，CXO 行业有望在下半年迎来业绩修复。报告指，美国出现不同的声音，但预期中美创新合作将持续。9月10日，纽约时报发文《TrumpWeighs Crackdown on Medicines From China》，提到特朗普政府目前有一项拟议中的行政命令草案，该草案可能切断来自中国的实验性治疗药物的引入渠道。然而，该命令草案引发了两个立场截然相反的团体展开激烈的游说活动。该行认为，美国大药企的收入、利润规模体量远大于美国Biotech企业，因此在游说中或许拥有更大的影响力。正如在Biosecure法案最终所看到的，中美的医药产业链紧密相连，强制脱钩将损害双方的利益。该行认为，中国丰富的工程师、科学家人才，以及高效、便宜的临床试验和药品生产能力是中国医药创新的核心竞争力，预期中国的药品创新研发和制造能力，将持续赋能全球药企。而美国针对创新药将加征关税，预期对CXO影响有限。特朗普于9月25日宣布，除非制药商正在美国建设工厂，否则从10月1日开始，专利药品将面临100%的关税。由于多家跨国药企已有美国建厂计划，因此或将不受影响。展望未来，该行认为创新药的持续上涨动力将主要来源于海外合作伙伴对于已授权管线的临床推动。此外，看好消费医疗的估值修复机会。推荐买入三生制药(01530)、巨子生物(02367)、药明合联(02268)、固生堂(02273)、中国生物制药(01177)、信达生物(01801) 。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2571142633","isCrawlerRequest":true}

招银国际：美国针对创新药将加征关税预期对CXO影响有限 推荐买入三生制药(01530)等

精彩评论

招银国际：美国针对创新药将加征关税预期对CXO影响有限推荐买入三生制药(01530)等